Our findings reveal that EA treatment inhibited IFN‐γ and TNF‐α production by CD8+ T cells in the uterus of pregnant lupus mice and improved the placental damage in lupus mice, thereby revealing the putative therapeutic benefit of EA in pSLE disease. This evidence concerns the gene CD8A and systemic lupus erythematosus.